Best of the Brokers for 10 September 2013

Liberum has upgraded the chipmaker from “hold” to “buy” with a 550p price target. The broker thinks CSR could beat its earnings forecasts in 2014 thanks to a raft of new products, and points to a 20 per cent fall in the share price since July as a good buying opportunity.

UBS has cut its rating on the sugar firm from “neutral” to “sell” and reduced its target from 890p to 770p. While the broker acknowledges Tate & Lyle’s strong balance sheet, it reckons the firm is learning towards acquisitions rather than returning its cash to shareholders.

Panmure Gordon has updated its score-sheet for the football pitch company, handing it a “buy” rating, up from a “hold”, and almost doubling its target price to 213p. The broker thinks Goals is turning a corner, with debts falling and like-for-like sales improving.